(R)-adrenaline multiple interactions ISO GRK5 (Homo sapiens) 6480464 Epinephrine promotes the reaction [GRK5 protein results in increased phosphorylation of ADRB2 protein] CTD PMID:14722251 17beta-estradiol multiple interactions ISO GRK5 (Homo sapiens) 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of GRK5 mRNA CTD PMID:30165855 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Grk5 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of GRK5 mRNA CTD PMID:19770486 and PMID:19933214 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of GRK5 mRNA CTD PMID:33387578 and PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO GRK5 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in increased expression of GRK5 mRNA CTD PMID:20106945 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Grk5 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of GRK5 mRNA CTD PMID:21570461 and PMID:28922406 2-hydroxypropanoic acid decreases expression ISO GRK5 (Homo sapiens) 6480464 Lactic Acid results in decreased expression of GRK5 mRNA CTD PMID:30851411 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:23196670 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO GRK5 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of GRK5 mRNA more ... CTD PMID:28628672 4,4'-sulfonyldiphenol multiple interactions ISO GRK5 (Homo sapiens) 6480464 [bisphenol S co-treated with Fulvestrant] results in increased methylation of GRK5 gene and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of GRK5 mRNA CTD PMID:28628672 and PMID:31601247 4,4'-sulfonyldiphenol affects methylation ISO Grk5 (Mus musculus) 6480464 bisphenol S affects the methylation of GRK5 gene CTD PMID:31683443 4,4'-sulfonyldiphenol increases expression ISO Grk5 (Mus musculus) 6480464 bisphenol S results in increased expression of GRK5 mRNA CTD PMID:33297965 4-hydroxyphenyl retinamide decreases expression ISO Grk5 (Mus musculus) 6480464 Fenretinide results in decreased expression of GRK5 mRNA CTD PMID:28973697 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of GRK5 mRNA CTD PMID:24780913 and PMID:30047161 acetamide increases expression EXP 6480464 acetamide results in increased expression of GRK5 mRNA CTD PMID:31881176 aflatoxin B1 affects expression ISO GRK5 (Homo sapiens) 6480464 Aflatoxin B1 affects the expression of GRK5 protein CTD PMID:20106945 aflatoxin B1 decreases methylation ISO GRK5 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of GRK5 intron CTD PMID:30157460 aflatoxin B1 decreases expression ISO Grk5 (Mus musculus) 6480464 Aflatoxin B1 results in decreased expression of GRK5 mRNA CTD PMID:19770486 Aflatoxin B2 alpha affects methylation ISO GRK5 (Homo sapiens) 6480464 aflatoxin B2 affects the methylation of GRK5 intron CTD PMID:30157460 amitrole decreases expression EXP 6480464 Amitrole results in decreased expression of GRK5 mRNA CTD PMID:30047161 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of GRK5 mRNA CTD PMID:16483693 arsane affects methylation ISO GRK5 (Homo sapiens) 6480464 Arsenic affects the methylation of GRK5 gene CTD PMID:25304211 arsenic atom affects methylation ISO GRK5 (Homo sapiens) 6480464 Arsenic affects the methylation of GRK5 gene CTD PMID:25304211 atrazine affects methylation EXP 6480464 Atrazine affects the methylation of GRK5 gene CTD PMID:28931070 benzo[a]pyrene decreases expression ISO Grk5 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of GRK5 mRNA CTD PMID:19770486 benzo[a]pyrene affects methylation ISO GRK5 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of GRK5 intron CTD PMID:30157460 benzo[a]pyrene decreases expression ISO GRK5 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of GRK5 mRNA CTD PMID:20064835 more ... benzo[a]pyrene affects expression ISO GRK5 (Homo sapiens) 6480464 Benzo(a)pyrene affects the expression of GRK5 mRNA CTD PMID:21714911 benzo[a]pyrene increases expression ISO Grk5 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of GRK5 mRNA CTD PMID:22228805 benzo[a]pyrene diol epoxide I decreases expression ISO GRK5 (Homo sapiens) 6480464 7 more ... CTD PMID:19150397 and PMID:26238291 benzo[e]pyrene increases methylation ISO GRK5 (Homo sapiens) 6480464 benzo(e)pyrene results in increased methylation of GRK5 intron CTD PMID:30157460 bis(2-ethylhexyl) phthalate decreases expression ISO Grk5 (Mus musculus) 6480464 Diethylhexyl Phthalate results in decreased expression of GRK5 mRNA CTD PMID:19850644 bis(2-ethylhexyl) phthalate multiple interactions ISO Grk5 (Mus musculus) 6480464 PPARA protein promotes the reaction [Diethylhexyl Phthalate results in decreased expression of GRK5 mRNA] CTD PMID:19850644 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of GRK5 mRNA CTD PMID:25181051 bisphenol A decreases methylation ISO GRK5 (Homo sapiens) 6480464 bisphenol A results in decreased methylation of GRK5 gene CTD PMID:31601247 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of GRK5 mRNA CTD PMID:30816183 bisphenol A increases expression ISO GRK5 (Homo sapiens) 6480464 bisphenol A results in increased expression of GRK5 mRNA CTD PMID:29275510 bisphenol A multiple interactions ISO GRK5 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of GRK5 mRNA CTD PMID:28628672 bisphenol A increases expression ISO Grk5 (Mus musculus) 6480464 bisphenol A results in increased expression of GRK5 mRNA CTD PMID:25594700 bisphenol F decreases expression EXP 6480464 4 and 4'-bisphenol F results in decreased expression of GRK5 mRNA CTD PMID:26186136 bisphenol F multiple interactions ISO GRK5 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of GRK5 mRNA CTD PMID:28628672 cadmium sulfate increases expression ISO GRK5 (Homo sapiens) 6480464 cadmium sulfate results in increased expression of GRK5 mRNA CTD PMID:21783983 caffeine affects phosphorylation ISO GRK5 (Homo sapiens) 6480464 Caffeine affects the phosphorylation of GRK5 protein CTD PMID:35688186 calciol increases expression ISO Grk5 (Mus musculus) 6480464 Cholecalciferol results in increased expression of GRK5 mRNA CTD PMID:16508948 calcitriol multiple interactions ISO GRK5 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of GRK5 mRNA CTD PMID:21592394 calcitriol increases expression ISO GRK5 (Homo sapiens) 6480464 Calcitriol results in increased expression of GRK5 mRNA CTD PMID:16002434 and PMID:21592394 carbon nanotube decreases expression ISO Grk5 (Mus musculus) 6480464 Nanotubes and Carbon analog results in decreased expression of GRK5 mRNA CTD PMID:25620056 carbon nanotube increases expression ISO Grk5 (Mus musculus) 6480464 Nanotubes and Carbon results in increased expression of GRK5 mRNA CTD PMID:25554681 carvedilol multiple interactions ISO GRK5 (Homo sapiens) 6480464 GRK5 mutant form inhibits the reaction [[carvedilol co-treated with ARRB1 protein] results in increased expression of MIR190A mRNA] CTD PMID:24334028 carvedilol multiple interactions ISO Grk5 (Mus musculus) 6480464 GRK5 gene mutant form inhibits the reaction [carvedilol results in increased expression of MIR125A mRNA] more ... CTD PMID:24334028 choline multiple interactions ISO Grk5 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of GRK5 mRNA CTD PMID:20938992 cisplatin decreases expression ISO GRK5 (Homo sapiens) 6480464 Cisplatin results in decreased expression of GRK5 mRNA CTD PMID:19561079 cobalt dichloride decreases expression ISO GRK5 (Homo sapiens) 6480464 cobaltous chloride results in decreased expression of GRK5 mRNA CTD PMID:19320972 copper(II) sulfate decreases expression ISO GRK5 (Homo sapiens) 6480464 Copper Sulfate results in decreased expression of GRK5 mRNA CTD PMID:19549813 corticosterone increases expression EXP 6480464 Corticosterone results in increased expression of GRK5 mRNA CTD PMID:15755911 crocidolite asbestos decreases expression ISO GRK5 (Homo sapiens) 6480464 Asbestos and Crocidolite results in decreased expression of GRK5 mRNA CTD PMID:29523930 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of GRK5 mRNA CTD PMID:26577399 cyclosporin A decreases expression ISO GRK5 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of GRK5 mRNA CTD PMID:20106945 cyclosporin A decreases expression ISO Grk5 (Mus musculus) 6480464 Cyclosporine results in decreased expression of GRK5 mRNA CTD PMID:19770486 cytarabine increases expression ISO GRK5 (Homo sapiens) 6480464 Cytarabine results in increased expression of GRK5 mRNA CTD PMID:19194470 dexamethasone increases expression ISO GRK5 (Homo sapiens) 6480464 Dexamethasone results in increased expression of GRK5 mRNA CTD PMID:25047013 dexamethasone multiple interactions ISO GRK5 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of GRK5 mRNA more ... CTD PMID:28628672 diuron increases expression EXP 6480464 Diuron results in increased expression of GRK5 mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO GRK5 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GRK5 mRNA CTD PMID:27188386 doxorubicin increases expression ISO Grk5 (Mus musculus) 6480464 Doxorubicin results in increased expression of GRK5 mRNA CTD PMID:25896364 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of GRK5 mRNA CTD PMID:29391264 epoxiconazole increases expression ISO Grk5 (Mus musculus) 6480464 epoxiconazole results in increased expression of GRK5 mRNA CTD PMID:35436446 ethanol affects splicing ISO Grk5 (Mus musculus) 6480464 Ethanol affects the splicing of GRK5 mRNA CTD PMID:30319688 fipronil increases expression EXP 6480464 fipronil results in increased expression of GRK5 mRNA CTD PMID:23962444 folic acid multiple interactions ISO Grk5 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of GRK5 mRNA CTD PMID:20938992 fulvestrant multiple interactions ISO GRK5 (Homo sapiens) 6480464 [bisphenol S co-treated with Fulvestrant] results in increased methylation of GRK5 gene CTD PMID:31601247 gamma-linolenic acid increases expression ISO GRK5 (Homo sapiens) 6480464 gamma-Linolenic Acid results in increased expression of GRK5 mRNA CTD PMID:20664735 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of GRK5 mRNA CTD PMID:33387578 hydrogen peroxide affects expression ISO GRK5 (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of GRK5 mRNA CTD PMID:20044591 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of GRK5 mRNA CTD PMID:21396975 indometacin multiple interactions ISO GRK5 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of GRK5 mRNA more ... CTD PMID:28628672 isoprenaline increases expression ISO Grk5 (Mus musculus) 6480464 Isoproterenol results in increased expression of GRK5 mRNA CTD PMID:20003209 L-methionine multiple interactions ISO Grk5 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of GRK5 mRNA CTD PMID:20938992 lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of GRK5 mRNA CTD PMID:11578147 lead diacetate multiple interactions ISO Grk5 (Mus musculus) 6480464 [lead acetate results in increased abundance of Lead] which results in decreased expression of GRK5 mRNA CTD PMID:33445541 lead(0) multiple interactions ISO Grk5 (Mus musculus) 6480464 [lead acetate results in increased abundance of Lead] which results in decreased expression of GRK5 mRNA CTD PMID:33445541 leflunomide increases expression ISO GRK5 (Homo sapiens) 6480464 leflunomide results in increased expression of GRK5 mRNA CTD PMID:28988120 melphalan decreases expression ISO GRK5 (Homo sapiens) 6480464 Melphalan results in decreased expression of GRK5 mRNA CTD PMID:22363485 menadione affects expression ISO GRK5 (Homo sapiens) 6480464 Vitamin K 3 affects the expression of GRK5 mRNA CTD PMID:20044591 methapyrilene increases methylation ISO GRK5 (Homo sapiens) 6480464 Methapyrilene results in increased methylation of GRK5 intron CTD PMID:30157460 methimazole decreases expression EXP 6480464 Methimazole results in decreased expression of GRK5 mRNA CTD PMID:30047161 methylseleninic acid increases expression ISO GRK5 (Homo sapiens) 6480464 methylselenic acid results in increased expression of GRK5 mRNA CTD PMID:18548127 metoprolol affects response to substance ISO Grk5 (Mus musculus) 6480464 GRK5 protein affects the susceptibility to Metoprolol CTD PMID:22888001 morphine increases expression EXP 6480464 Morphine results in increased expression of GRK5 mRNA CTD PMID:15183518 nitrobenzenes decreases expression EXP 6480464 Nitrobenzenes analog results in decreased expression of GRK5 mRNA CTD PMID:19784758 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of GRK5 mRNA CTD PMID:25729387 ozone decreases expression EXP 6480464 Ozone results in decreased expression of GRK5 mRNA CTD PMID:16330353 ozone multiple interactions ISO Grk5 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of GRK5 mRNA CTD PMID:34911549 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of GRK5 mRNA CTD PMID:19784758 paracetamol increases expression ISO GRK5 (Homo sapiens) 6480464 Acetaminophen results in increased expression of GRK5 mRNA CTD PMID:29067470 paracetamol multiple interactions ISO Grk5 (Mus musculus) 6480464 PANX1 gene mutant form inhibits the reaction [Acetaminophen results in increased expression of GRK5 mRNA] CTD PMID:29246445 paracetamol increases expression ISO Grk5 (Mus musculus) 6480464 Acetaminophen results in increased expression of GRK5 mRNA CTD PMID:29246445 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of GRK5 mRNA CTD PMID:19784758 and PMID:33387578 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of GRK5 mRNA CTD PMID:19784758 parathion decreases expression ISO Grk5 (Mus musculus) 6480464 Parathion results in decreased expression of GRK5 mRNA CTD PMID:34813904 perfluorohexanesulfonic acid increases expression ISO Grk5 (Mus musculus) 6480464 perfluorohexanesulfonic acid results in increased expression of GRK5 mRNA CTD PMID:37995155 phenobarbital multiple interactions ISO Grk5 (Mus musculus) 6480464 NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of GRK5 mRNA] CTD PMID:19482888 phenobarbital affects expression ISO Grk5 (Mus musculus) 6480464 Phenobarbital affects the expression of GRK5 mRNA CTD PMID:23091169 phenobarbital affects expression ISO GRK5 (Homo sapiens) 6480464 Phenobarbital affects the expression of GRK5 mRNA CTD PMID:19159669 phenobarbital decreases expression ISO Grk5 (Mus musculus) 6480464 Phenobarbital results in decreased expression of GRK5 mRNA CTD PMID:19270015 and PMID:19482888 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of GRK5 mRNA CTD PMID:19162173 phenobarbital increases expression ISO Grk5 (Mus musculus) 6480464 Phenobarbital results in increased expression of GRK5 mRNA CTD PMID:19270015 pirinixic acid multiple interactions ISO GRK5 (Homo sapiens) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of GRK5 mRNA CTD PMID:19710929 pirinixic acid decreases expression ISO Grk5 (Mus musculus) 6480464 pirinixic acid results in decreased expression of GRK5 mRNA CTD PMID:16985257 pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of GRK5 mRNA CTD PMID:19162173 rac-lactic acid decreases expression ISO GRK5 (Homo sapiens) 6480464 Lactic Acid results in decreased expression of GRK5 mRNA CTD PMID:30851411 raloxifene affects expression ISO GRK5 (Homo sapiens) 6480464 Raloxifene Hydrochloride affects the expression of GRK5 mRNA CTD PMID:14699072 raloxifene multiple interactions ISO GRK5 (Homo sapiens) 6480464 [Raloxifene Hydrochloride co-treated with ESR1 protein] results in increased expression of GRK5 mRNA CTD PMID:19059307 resveratrol multiple interactions ISO GRK5 (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of GRK5 mRNA CTD PMID:23557933 SB 431542 multiple interactions ISO GRK5 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GRK5 mRNA CTD PMID:27188386 sulfadimethoxine decreases expression EXP 6480464 Sulfadimethoxine results in decreased expression of GRK5 mRNA CTD PMID:30047161 sunitinib increases expression ISO GRK5 (Homo sapiens) 6480464 Sunitinib results in increased expression of GRK5 mRNA CTD PMID:31533062 tamoxifen affects expression ISO GRK5 (Homo sapiens) 6480464 Tamoxifen affects the expression of GRK5 mRNA CTD PMID:14699072 tamoxifen multiple interactions ISO GRK5 (Homo sapiens) 6480464 [Tamoxifen co-treated with ESR1 protein] results in increased expression of GRK5 mRNA CTD PMID:19059307 temozolomide decreases expression ISO GRK5 (Homo sapiens) 6480464 Temozolomide results in decreased expression of GRK5 mRNA CTD PMID:31758290 testosterone multiple interactions ISO GRK5 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of GRK5 mRNA CTD PMID:21592394 testosterone decreases expression ISO GRK5 (Homo sapiens) 6480464 Testosterone results in decreased expression of GRK5 mRNA CTD PMID:21592394 tetrachloroethene decreases expression ISO Grk5 (Mus musculus) 6480464 Tetrachloroethylene results in decreased expression of GRK5 mRNA CTD PMID:28973375 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of GRK5 mRNA CTD PMID:16644059 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of GRK5 mRNA CTD PMID:19784758 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of GRK5 mRNA CTD PMID:19784758 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of GRK5 mRNA CTD PMID:34492290 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of GRK5 mRNA CTD PMID:25729387 tributylstannane decreases expression ISO Grk5 (Mus musculus) 6480464 tributyltin results in decreased expression of GRK5 mRNA CTD PMID:31939706 trichloroethene decreases expression ISO Grk5 (Mus musculus) 6480464 Trichloroethylene results in decreased expression of GRK5 mRNA CTD PMID:19448997 and PMID:28973375 trichostatin A increases expression ISO GRK5 (Homo sapiens) 6480464 trichostatin A results in increased expression of GRK5 mRNA CTD PMID:24935251 valproic acid decreases expression ISO GRK5 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of GRK5 mRNA CTD PMID:19101580 valproic acid increases expression ISO Grk5 (Mus musculus) 6480464 Valproic Acid results in increased expression of GRK5 mRNA CTD PMID:21427059 valproic acid affects expression ISO GRK5 (Homo sapiens) 6480464 Valproic Acid affects the expression of GRK5 mRNA CTD PMID:25979313 valproic acid increases expression ISO GRK5 (Homo sapiens) 6480464 Valproic Acid results in increased expression of GRK5 mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO GRK5 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GRK5 mRNA CTD PMID:27188386 vinclozolin decreases methylation EXP 6480464 vinclozolin results in decreased methylation of GRK5 gene CTD PMID:31079544 zoledronic acid increases expression ISO GRK5 (Homo sapiens) 6480464 zoledronic acid results in increased expression of GRK5 mRNA CTD PMID:24714768
